查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1760880

全球血液学诊断市场

Hematology Diagnostics
出版日期: | 出版商: Global Industry Analysts, Inc. | 英文 174 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

简介目录

到 2030 年，全球血液学诊断市场规模将达到 119 亿美元

全球血液学诊断市场规模预计在2024年为85亿美元，预计到2030年将达到119亿美元，2024年至2030年的复合年增长率为5.8%。报告分析的细分市场之一——耗材——预计复合年增长率为5.4%，到分析期结束时规模将达到78亿美元。在分析期间内，设备细分市场的复合年增长率预计为6.7%。

美国市场规模估计为 22 亿美元，中国市场预期复合年增长率为 9.2%

美国血液诊断市场规模预计在2024年达到22亿美元。作为世界第二大经济体，中国预计到2030年市场规模将达到27亿美元，在2024-2030年的分析期间内，复合年增长率为9.2%。其他值得关注的区域市场包括日本和加拿大，预计在分析期间内，这两个市场的复合年增长率分别为3.0%和4.9%。在欧洲，预计德国市场的复合年增长率为3.9%。

全球血液学诊断市场—主要趋势与驱动因素摘要

为什么血液诊断对现代医疗保健至关重要？

血液学诊断对于诊断和监测血液相关疾病至关重要，包括贫血、感染疾病以及白血病等骨髓恶性肿瘤。这些检测能够提供有关血球计数、凝血状态和细胞形态的宝贵资讯，有助于疾病检测和治疗监测。由于医疗保健系统重视早期诊断和预防医学，血液学诊断对于早期发现异常情况并及时介入至关重要。血液学在评估整体健康状况和诊断严重方面发挥着重要作用，这使得这些诊断方法成为医学实验室的支柱。

科技进步如何提高诊断的准确性？

血液学诊断技术的进步正在提高检测的准确性、速度和自动化程度。如今，自动化分析仪能够提供快速、高通量的结果，减少人工劳动，并最大限度地减少人为错误。流式细胞技术和数位成像等技术创新使得详细的细胞分析成为可能，从而实现更准确的诊断。即时血液学分析仪也越来越普及，能够在门诊快速提供结果，并支持及时的临床决策。这些进步使血液学诊断更加便捷、高效和可靠，使患者和医疗保健提供者都能从中受益。

为什么对照护现场血液诊断的需求不断增加？

随着医疗保健提供者寻求提供更快的诊断速度并改善患者体验，对照护现场血液诊断 (POC) 的需求日益增长。 POC 血液学检测非常适合传统实验室以外的场所，例如诊所和急诊科，在这些场所，快速获得结果对于决策至关重要。便携式 POC 设备使医疗保健提供者能够在更靠近患者的地方进行检测，从而促进即时治疗并减少多次预约的需求。这一趋势与医疗保健向去中心化和以患者为中心的解决方案的广泛转变相吻合，这些解决方案优先考虑可及性和效率。

是什么推动了血液学诊断市场的成长？

血液学诊断市场的成长动力源于对疾病早期检测日益增长的需求、自动化诊断技术的进步以及就地检验）的日益普及。随着医疗保健系统对预防医学的重视，对早期检测的追求也推动了血液学检测的需求。技术创新正在提高诊断的准确性和速度，使得自动化血液学系统成为医学实验室不可或缺的一部分。此外，POC诊断的日益普及反映了医疗保健向可及性和以患者为中心的转变，随着血液学诊断技术不断发展以满足现代医疗保健的需求，POC诊断市场将进一步扩张。

部分

产品类型（血球计数、血小板功能、血红素、红血球压积症）、最终用户（医院、诊断实验室、其他最终用户）

调查企业范例（共43家企业）

  • Abbott Laboratories
  • Beckman Coulter, Inc.
  • F. Hoffmann-La Roche AG
  • Mindray Medical International Ltd.
  • Siemens Healthineers
  • Sysmex Corporation

人工智慧集成

全球产业分析师正在利用可操作的专家内容和人工智慧工具改变市场和竞争情报。

Global Industry Analysts 并未遵循典型的 LLM 或特定产业的 SLM查询，而是建立了一个从全球专家收集的内容库，其中包括影片录影、部落格、搜寻引擎研究以及大量的公司、产品/服务和市场数据。

关税影响係数

全球产业分析师根据公司总部所在国家、製造地、进出口状况（成品和原始OEM）预测其竞争态势的变化。这种复杂且多面向的市场动态预计将以多种方式影响竞争对手，包括销货成本成本 (COGS) 上升、盈利下降、供应链重组以及其他微观和宏观市场动态。

目录

第一章调查方法

第二章执行摘要

  • 市场概览
  • 主要企业
  • 市场趋势和驱动因素
  • 全球市场展望

第三章市场分析

  • 美国
  • 加拿大
  • 日本
  • 中国
  • 欧洲
  • 法国
  • 德国
  • 义大利
  • 英国
  • 西班牙
  • 俄罗斯
  • 其他欧洲国家
  • 亚太地区
  • 澳洲
  • 印度
  • 韩国
  • 其他亚太地区
  • 拉丁美洲
  • 阿根廷
  • 巴西
  • 墨西哥
  • 其他拉丁美洲
  • 中东
  • 伊朗
  • 以色列
  • 沙乌地阿拉伯
  • 阿拉伯聯合大公国
  • 其他中东地区
  • 非洲

第四章 竞赛

简介目录
Product Code: MCP16457

Global Hematology Diagnostics Market to Reach US$11.9 Billion by 2030

The global market for Hematology Diagnostics estimated at US$8.5 Billion in the year 2024, is expected to reach US$11.9 Billion by 2030, growing at a CAGR of 5.8% over the analysis period 2024-2030. Consumables, one of the segments analyzed in the report, is expected to record a 5.4% CAGR and reach US$7.8 Billion by the end of the analysis period. Growth in the Instruments segment is estimated at 6.7% CAGR over the analysis period.

The U.S. Market is Estimated at US$2.2 Billion While China is Forecast to Grow at 9.2% CAGR

The Hematology Diagnostics market in the U.S. is estimated at US$2.2 Billion in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$2.7 Billion by the year 2030 trailing a CAGR of 9.2% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 3.0% and 4.9% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 3.9% CAGR.

Global Hematology Diagnostics Market - Key Trends & Drivers Summarized

Why Are Hematology Diagnostics Essential in Modern Healthcare?

Hematology diagnostics are critical in diagnosing and monitoring blood-related diseases, including anemia, infections, and hematological malignancies like leukemia. These tests provide valuable insights into blood cell counts, coagulation status, and cellular morphology, aiding in disease detection and treatment monitoring. As healthcare systems prioritize early diagnosis and preventive care, hematology diagnostics are essential in identifying abnormalities early, allowing for timely intervention. The role of hematology in assessing general health and diagnosing serious conditions has made these diagnostics a mainstay in medical laboratories.

How Are Technological Advancements Improving Diagnostic Accuracy?

Technological advancements in hematology diagnostics are enhancing test accuracy, speed, and automation. Automated analyzers now provide rapid, high-throughput results, reducing manual processes and minimizing human error. Innovations such as flow cytometry and digital imaging enable detailed cellular analysis, allowing for more precise diagnoses. Point-of-care hematology analyzers are also becoming popular, offering rapid results in outpatient settings and supporting timely clinical decisions. These advancements are making hematology diagnostics more accessible, efficient, and reliable, benefiting both patients and healthcare providers.

Why Is the Demand for Point-of-Care Hematology Diagnostics Increasing?

The demand for point-of-care (POC) hematology diagnostics is growing as healthcare providers seek to deliver faster diagnoses and improve patient experience. POC hematology tests are ideal for settings outside traditional laboratories, such as clinics and emergency rooms, where quick results are essential for decision-making. Portable POC devices enable healthcare providers to perform tests closer to the patient, facilitating immediate care and reducing the need for multiple appointments. This trend aligns with the broader shift toward decentralized healthcare and patient-centric solutions, which prioritize accessibility and efficiency.

What Drives the Growth of the Hematology Diagnostics Market?

The growth in the hematology diagnostics market is driven by increased demand for early disease detection, advancements in automated diagnostics, and the rising adoption of point-of-care testing. Early detection initiatives support demand for hematology tests as healthcare systems emphasize preventive care. Technological innovations are enhancing diagnostic accuracy and speed, making automated hematology systems essential in medical laboratories. Additionally, the growing popularity of POC diagnostics reflects a shift toward accessible, patient-centered care, further fueling market expansion as hematology diagnostics evolve to meet modern healthcare needs.

SCOPE OF STUDY:

The report analyzes the Hematology Diagnostics market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:

Product (Consumables, Instruments); Test Type (Blood Count, Platelet Function, Hemoglobin, Hematocrit); End-Use (Hospitals, Diagnostic Laboratories, Other End-Uses)

Geographic Regions/Countries:

World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; Spain; Russia; and Rest of Europe); Asia-Pacific (Australia; India; South Korea; and Rest of Asia-Pacific); Latin America (Argentina; Brazil; Mexico; and Rest of Latin America); Middle East (Iran; Israel; Saudi Arabia; United Arab Emirates; and Rest of Middle East); and Africa.

Select Competitors (Total 43 Featured) -

  • Abbott Laboratories
  • Beckman Coulter, Inc.
  • F. Hoffmann-La Roche AG
  • Mindray Medical International Ltd.
  • Siemens Healthineers
  • Sysmex Corporation

AI INTEGRATIONS

We're transforming market and competitive intelligence with validated expert content and AI tools.

Instead of following the general norm of querying LLMs and Industry-specific SLMs, we built repositories of content curated from domain experts worldwide including video transcripts, blogs, search engines research, and massive amounts of enterprise, product/service, and market data.

TARIFF IMPACT FACTOR

Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by increasing the Cost of Goods Sold (COGS), reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • Tariff Impact on Global Supply Chain Patterns
    • Tariff Impact on Global Supply Chain Patterns
    • Hematology Diagnostics - Global Key Competitors Percentage Market Share in 2025 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2025 (E)
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • Rising Demand for Early and Accurate Diagnosis of Blood Disorders
    • Growth in Automated Hematology Analyzers for Precision Diagnostics
    • Advancements in Hematology Test Accuracy and Result Speed
    • Increased Use of Point-of-Care Hematology Testing Solutions
    • Expansion of Hematology Diagnostics in Oncology and Chronic Disease
    • Higher Demand for Molecular Diagnostics in Hematology
    • Development of AI and Big Data for Hematology Test Analysis
    • Growing Need for Advanced Hematology Tests in Emerging Markets
    • Expansion of Digital Hematology for Remote Diagnosis
    • Increasing Adoption of Complete Blood Count (CBC) Testing
    • Rising Interest in Multiparameter Analysis for Blood Diagnostics
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Hematology Diagnostics Market Analysis of Annual Sales in US$ Million for Years 2015 through 2030
    • TABLE 2: World Recent Past, Current & Future Analysis for Hematology Diagnostics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 3: World Historic Review for Hematology Diagnostics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 4: World 15-Year Perspective for Hematology Diagnostics by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2015, 2025 & 2030
    • TABLE 5: World Recent Past, Current & Future Analysis for Consumables by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 6: World Historic Review for Consumables by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 7: World 15-Year Perspective for Consumables by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 8: World Recent Past, Current & Future Analysis for Instruments by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 9: World Historic Review for Instruments by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 10: World 15-Year Perspective for Instruments by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 11: World Recent Past, Current & Future Analysis for Blood count by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 12: World Historic Review for Blood count by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 13: World 15-Year Perspective for Blood count by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 14: World Recent Past, Current & Future Analysis for Platelet function by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 15: World Historic Review for Platelet function by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 16: World 15-Year Perspective for Platelet function by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 17: World Recent Past, Current & Future Analysis for Hemoglobin by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 18: World Historic Review for Hemoglobin by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 19: World 15-Year Perspective for Hemoglobin by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 20: World Recent Past, Current & Future Analysis for Hematocrit by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 21: World Historic Review for Hematocrit by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 22: World 15-Year Perspective for Hematocrit by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 23: World Recent Past, Current & Future Analysis for Hospitals by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 24: World Historic Review for Hospitals by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 25: World 15-Year Perspective for Hospitals by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 26: World Recent Past, Current & Future Analysis for Diagnostic Laboratories by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 27: World Historic Review for Diagnostic Laboratories by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 28: World 15-Year Perspective for Diagnostic Laboratories by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 29: World Recent Past, Current & Future Analysis for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 30: World Historic Review for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 31: World 15-Year Perspective for Other End-Uses by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • Hematology Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2025 (E)
    • TABLE 32: USA Recent Past, Current & Future Analysis for Hematology Diagnostics by Product - Consumables and Instruments - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 33: USA Historic Review for Hematology Diagnostics by Product - Consumables and Instruments Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 34: USA 15-Year Perspective for Hematology Diagnostics by Product - Percentage Breakdown of Value Sales for Consumables and Instruments for the Years 2015, 2025 & 2030
    • TABLE 35: USA Recent Past, Current & Future Analysis for Hematology Diagnostics by Test Type - Blood count, Platelet function, Hemoglobin and Hematocrit - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 36: USA Historic Review for Hematology Diagnostics by Test Type - Blood count, Platelet function, Hemoglobin and Hematocrit Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 37: USA 15-Year Perspective for Hematology Diagnostics by Test Type - Percentage Breakdown of Value Sales for Blood count, Platelet function, Hemoglobin and Hematocrit for the Years 2015, 2025 & 2030
    • TABLE 38: USA Recent Past, Current & Future Analysis for Hematology Diagnostics by End-Use - Hospitals, Diagnostic Laboratories and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 39: USA Historic Review for Hematology Diagnostics by End-Use - Hospitals, Diagnostic Laboratories and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 40: USA 15-Year Perspective for Hematology Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals, Diagnostic Laboratories and Other End-Uses for the Years 2015, 2025 & 2030
  • CANADA
    • TABLE 41: Canada Recent Past, Current & Future Analysis for Hematology Diagnostics by Product - Consumables and Instruments - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 42: Canada Historic Review for Hematology Diagnostics by Product - Consumables and Instruments Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 43: Canada 15-Year Perspective for Hematology Diagnostics by Product - Percentage Breakdown of Value Sales for Consumables and Instruments for the Years 2015, 2025 & 2030
    • TABLE 44: Canada Recent Past, Current & Future Analysis for Hematology Diagnostics by Test Type - Blood count, Platelet function, Hemoglobin and Hematocrit - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 45: Canada Historic Review for Hematology Diagnostics by Test Type - Blood count, Platelet function, Hemoglobin and Hematocrit Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 46: Canada 15-Year Perspective for Hematology Diagnostics by Test Type - Percentage Breakdown of Value Sales for Blood count, Platelet function, Hemoglobin and Hematocrit for the Years 2015, 2025 & 2030
    • TABLE 47: Canada Recent Past, Current & Future Analysis for Hematology Diagnostics by End-Use - Hospitals, Diagnostic Laboratories and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 48: Canada Historic Review for Hematology Diagnostics by End-Use - Hospitals, Diagnostic Laboratories and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 49: Canada 15-Year Perspective for Hematology Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals, Diagnostic Laboratories and Other End-Uses for the Years 2015, 2025 & 2030
  • JAPAN
    • Hematology Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2025 (E)
    • TABLE 50: Japan Recent Past, Current & Future Analysis for Hematology Diagnostics by Product - Consumables and Instruments - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 51: Japan Historic Review for Hematology Diagnostics by Product - Consumables and Instruments Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 52: Japan 15-Year Perspective for Hematology Diagnostics by Product - Percentage Breakdown of Value Sales for Consumables and Instruments for the Years 2015, 2025 & 2030
    • TABLE 53: Japan Recent Past, Current & Future Analysis for Hematology Diagnostics by Test Type - Blood count, Platelet function, Hemoglobin and Hematocrit - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 54: Japan Historic Review for Hematology Diagnostics by Test Type - Blood count, Platelet function, Hemoglobin and Hematocrit Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 55: Japan 15-Year Perspective for Hematology Diagnostics by Test Type - Percentage Breakdown of Value Sales for Blood count, Platelet function, Hemoglobin and Hematocrit for the Years 2015, 2025 & 2030
    • TABLE 56: Japan Recent Past, Current & Future Analysis for Hematology Diagnostics by End-Use - Hospitals, Diagnostic Laboratories and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 57: Japan Historic Review for Hematology Diagnostics by End-Use - Hospitals, Diagnostic Laboratories and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 58: Japan 15-Year Perspective for Hematology Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals, Diagnostic Laboratories and Other End-Uses for the Years 2015, 2025 & 2030
  • CHINA
    • Hematology Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2025 (E)
    • TABLE 59: China Recent Past, Current & Future Analysis for Hematology Diagnostics by Product - Consumables and Instruments - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 60: China Historic Review for Hematology Diagnostics by Product - Consumables and Instruments Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 61: China 15-Year Perspective for Hematology Diagnostics by Product - Percentage Breakdown of Value Sales for Consumables and Instruments for the Years 2015, 2025 & 2030
    • TABLE 62: China Recent Past, Current & Future Analysis for Hematology Diagnostics by Test Type - Blood count, Platelet function, Hemoglobin and Hematocrit - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 63: China Historic Review for Hematology Diagnostics by Test Type - Blood count, Platelet function, Hemoglobin and Hematocrit Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 64: China 15-Year Perspective for Hematology Diagnostics by Test Type - Percentage Breakdown of Value Sales for Blood count, Platelet function, Hemoglobin and Hematocrit for the Years 2015, 2025 & 2030
    • TABLE 65: China Recent Past, Current & Future Analysis for Hematology Diagnostics by End-Use - Hospitals, Diagnostic Laboratories and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 66: China Historic Review for Hematology Diagnostics by End-Use - Hospitals, Diagnostic Laboratories and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 67: China 15-Year Perspective for Hematology Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals, Diagnostic Laboratories and Other End-Uses for the Years 2015, 2025 & 2030
  • EUROPE
    • Hematology Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2025 (E)
    • TABLE 68: Europe Recent Past, Current & Future Analysis for Hematology Diagnostics by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 69: Europe Historic Review for Hematology Diagnostics by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 70: Europe 15-Year Perspective for Hematology Diagnostics by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2015, 2025 & 2030
    • TABLE 71: Europe Recent Past, Current & Future Analysis for Hematology Diagnostics by Product - Consumables and Instruments - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 72: Europe Historic Review for Hematology Diagnostics by Product - Consumables and Instruments Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 73: Europe 15-Year Perspective for Hematology Diagnostics by Product - Percentage Breakdown of Value Sales for Consumables and Instruments for the Years 2015, 2025 & 2030
    • TABLE 74: Europe Recent Past, Current & Future Analysis for Hematology Diagnostics by Test Type - Blood count, Platelet function, Hemoglobin and Hematocrit - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 75: Europe Historic Review for Hematology Diagnostics by Test Type - Blood count, Platelet function, Hemoglobin and Hematocrit Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 76: Europe 15-Year Perspective for Hematology Diagnostics by Test Type - Percentage Breakdown of Value Sales for Blood count, Platelet function, Hemoglobin and Hematocrit for the Years 2015, 2025 & 2030
    • TABLE 77: Europe Recent Past, Current & Future Analysis for Hematology Diagnostics by End-Use - Hospitals, Diagnostic Laboratories and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 78: Europe Historic Review for Hematology Diagnostics by End-Use - Hospitals, Diagnostic Laboratories and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 79: Europe 15-Year Perspective for Hematology Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals, Diagnostic Laboratories and Other End-Uses for the Years 2015, 2025 & 2030
  • FRANCE
    • Hematology Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2025 (E)
    • TABLE 80: France Recent Past, Current & Future Analysis for Hematology Diagnostics by Product - Consumables and Instruments - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 81: France Historic Review for Hematology Diagnostics by Product - Consumables and Instruments Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 82: France 15-Year Perspective for Hematology Diagnostics by Product - Percentage Breakdown of Value Sales for Consumables and Instruments for the Years 2015, 2025 & 2030
    • TABLE 83: France Recent Past, Current & Future Analysis for Hematology Diagnostics by Test Type - Blood count, Platelet function, Hemoglobin and Hematocrit - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 84: France Historic Review for Hematology Diagnostics by Test Type - Blood count, Platelet function, Hemoglobin and Hematocrit Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 85: France 15-Year Perspective for Hematology Diagnostics by Test Type - Percentage Breakdown of Value Sales for Blood count, Platelet function, Hemoglobin and Hematocrit for the Years 2015, 2025 & 2030
    • TABLE 86: France Recent Past, Current & Future Analysis for Hematology Diagnostics by End-Use - Hospitals, Diagnostic Laboratories and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 87: France Historic Review for Hematology Diagnostics by End-Use - Hospitals, Diagnostic Laboratories and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 88: France 15-Year Perspective for Hematology Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals, Diagnostic Laboratories and Other End-Uses for the Years 2015, 2025 & 2030
  • GERMANY
    • Hematology Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2025 (E)
    • TABLE 89: Germany Recent Past, Current & Future Analysis for Hematology Diagnostics by Product - Consumables and Instruments - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 90: Germany Historic Review for Hematology Diagnostics by Product - Consumables and Instruments Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 91: Germany 15-Year Perspective for Hematology Diagnostics by Product - Percentage Breakdown of Value Sales for Consumables and Instruments for the Years 2015, 2025 & 2030
    • TABLE 92: Germany Recent Past, Current & Future Analysis for Hematology Diagnostics by Test Type - Blood count, Platelet function, Hemoglobin and Hematocrit - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 93: Germany Historic Review for Hematology Diagnostics by Test Type - Blood count, Platelet function, Hemoglobin and Hematocrit Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 94: Germany 15-Year Perspective for Hematology Diagnostics by Test Type - Percentage Breakdown of Value Sales for Blood count, Platelet function, Hemoglobin and Hematocrit for the Years 2015, 2025 & 2030
    • TABLE 95: Germany Recent Past, Current & Future Analysis for Hematology Diagnostics by End-Use - Hospitals, Diagnostic Laboratories and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 96: Germany Historic Review for Hematology Diagnostics by End-Use - Hospitals, Diagnostic Laboratories and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 97: Germany 15-Year Perspective for Hematology Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals, Diagnostic Laboratories and Other End-Uses for the Years 2015, 2025 & 2030
  • ITALY
    • TABLE 98: Italy Recent Past, Current & Future Analysis for Hematology Diagnostics by Product - Consumables and Instruments - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 99: Italy Historic Review for Hematology Diagnostics by Product - Consumables and Instruments Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 100: Italy 15-Year Perspective for Hematology Diagnostics by Product - Percentage Breakdown of Value Sales for Consumables and Instruments for the Years 2015, 2025 & 2030
    • TABLE 101: Italy Recent Past, Current & Future Analysis for Hematology Diagnostics by Test Type - Blood count, Platelet function, Hemoglobin and Hematocrit - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 102: Italy Historic Review for Hematology Diagnostics by Test Type - Blood count, Platelet function, Hemoglobin and Hematocrit Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 103: Italy 15-Year Perspective for Hematology Diagnostics by Test Type - Percentage Breakdown of Value Sales for Blood count, Platelet function, Hemoglobin and Hematocrit for the Years 2015, 2025 & 2030
    • TABLE 104: Italy Recent Past, Current & Future Analysis for Hematology Diagnostics by End-Use - Hospitals, Diagnostic Laboratories and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 105: Italy Historic Review for Hematology Diagnostics by End-Use - Hospitals, Diagnostic Laboratories and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 106: Italy 15-Year Perspective for Hematology Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals, Diagnostic Laboratories and Other End-Uses for the Years 2015, 2025 & 2030
  • UNITED KINGDOM
    • Hematology Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2025 (E)
    • TABLE 107: UK Recent Past, Current & Future Analysis for Hematology Diagnostics by Product - Consumables and Instruments - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 108: UK Historic Review for Hematology Diagnostics by Product - Consumables and Instruments Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 109: UK 15-Year Perspective for Hematology Diagnostics by Product - Percentage Breakdown of Value Sales for Consumables and Instruments for the Years 2015, 2025 & 2030
    • TABLE 110: UK Recent Past, Current & Future Analysis for Hematology Diagnostics by Test Type - Blood count, Platelet function, Hemoglobin and Hematocrit - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 111: UK Historic Review for Hematology Diagnostics by Test Type - Blood count, Platelet function, Hemoglobin and Hematocrit Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 112: UK 15-Year Perspective for Hematology Diagnostics by Test Type - Percentage Breakdown of Value Sales for Blood count, Platelet function, Hemoglobin and Hematocrit for the Years 2015, 2025 & 2030
    • TABLE 113: UK Recent Past, Current & Future Analysis for Hematology Diagnostics by End-Use - Hospitals, Diagnostic Laboratories and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 114: UK Historic Review for Hematology Diagnostics by End-Use - Hospitals, Diagnostic Laboratories and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 115: UK 15-Year Perspective for Hematology Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals, Diagnostic Laboratories and Other End-Uses for the Years 2015, 2025 & 2030
  • SPAIN
    • TABLE 116: Spain Recent Past, Current & Future Analysis for Hematology Diagnostics by Product - Consumables and Instruments - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 117: Spain Historic Review for Hematology Diagnostics by Product - Consumables and Instruments Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 118: Spain 15-Year Perspective for Hematology Diagnostics by Product - Percentage Breakdown of Value Sales for Consumables and Instruments for the Years 2015, 2025 & 2030
    • TABLE 119: Spain Recent Past, Current & Future Analysis for Hematology Diagnostics by Test Type - Blood count, Platelet function, Hemoglobin and Hematocrit - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 120: Spain Historic Review for Hematology Diagnostics by Test Type - Blood count, Platelet function, Hemoglobin and Hematocrit Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 121: Spain 15-Year Perspective for Hematology Diagnostics by Test Type - Percentage Breakdown of Value Sales for Blood count, Platelet function, Hemoglobin and Hematocrit for the Years 2015, 2025 & 2030
    • TABLE 122: Spain Recent Past, Current & Future Analysis for Hematology Diagnostics by End-Use - Hospitals, Diagnostic Laboratories and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 123: Spain Historic Review for Hematology Diagnostics by End-Use - Hospitals, Diagnostic Laboratories and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 124: Spain 15-Year Perspective for Hematology Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals, Diagnostic Laboratories and Other End-Uses for the Years 2015, 2025 & 2030
  • RUSSIA
    • TABLE 125: Russia Recent Past, Current & Future Analysis for Hematology Diagnostics by Product - Consumables and Instruments - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 126: Russia Historic Review for Hematology Diagnostics by Product - Consumables and Instruments Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 127: Russia 15-Year Perspective for Hematology Diagnostics by Product - Percentage Breakdown of Value Sales for Consumables and Instruments for the Years 2015, 2025 & 2030
    • TABLE 128: Russia Recent Past, Current & Future Analysis for Hematology Diagnostics by Test Type - Blood count, Platelet function, Hemoglobin and Hematocrit - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 129: Russia Historic Review for Hematology Diagnostics by Test Type - Blood count, Platelet function, Hemoglobin and Hematocrit Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 130: Russia 15-Year Perspective for Hematology Diagnostics by Test Type - Percentage Breakdown of Value Sales for Blood count, Platelet function, Hemoglobin and Hematocrit for the Years 2015, 2025 & 2030
    • TABLE 131: Russia Recent Past, Current & Future Analysis for Hematology Diagnostics by End-Use - Hospitals, Diagnostic Laboratories and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 132: Russia Historic Review for Hematology Diagnostics by End-Use - Hospitals, Diagnostic Laboratories and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 133: Russia 15-Year Perspective for Hematology Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals, Diagnostic Laboratories and Other End-Uses for the Years 2015, 2025 & 2030
  • REST OF EUROPE
    • TABLE 134: Rest of Europe Recent Past, Current & Future Analysis for Hematology Diagnostics by Product - Consumables and Instruments - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 135: Rest of Europe Historic Review for Hematology Diagnostics by Product - Consumables and Instruments Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 136: Rest of Europe 15-Year Perspective for Hematology Diagnostics by Product - Percentage Breakdown of Value Sales for Consumables and Instruments for the Years 2015, 2025 & 2030
    • TABLE 137: Rest of Europe Recent Past, Current & Future Analysis for Hematology Diagnostics by Test Type - Blood count, Platelet function, Hemoglobin and Hematocrit - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 138: Rest of Europe Historic Review for Hematology Diagnostics by Test Type - Blood count, Platelet function, Hemoglobin and Hematocrit Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 139: Rest of Europe 15-Year Perspective for Hematology Diagnostics by Test Type - Percentage Breakdown of Value Sales for Blood count, Platelet function, Hemoglobin and Hematocrit for the Years 2015, 2025 & 2030
    • TABLE 140: Rest of Europe Recent Past, Current & Future Analysis for Hematology Diagnostics by End-Use - Hospitals, Diagnostic Laboratories and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 141: Rest of Europe Historic Review for Hematology Diagnostics by End-Use - Hospitals, Diagnostic Laboratories and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 142: Rest of Europe 15-Year Perspective for Hematology Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals, Diagnostic Laboratories and Other End-Uses for the Years 2015, 2025 & 2030
  • ASIA-PACIFIC
    • Hematology Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2025 (E)
    • TABLE 143: Asia-Pacific Recent Past, Current & Future Analysis for Hematology Diagnostics by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 144: Asia-Pacific Historic Review for Hematology Diagnostics by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 145: Asia-Pacific 15-Year Perspective for Hematology Diagnostics by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2015, 2025 & 2030
    • TABLE 146: Asia-Pacific Recent Past, Current & Future Analysis for Hematology Diagnostics by Product - Consumables and Instruments - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 147: Asia-Pacific Historic Review for Hematology Diagnostics by Product - Consumables and Instruments Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 148: Asia-Pacific 15-Year Perspective for Hematology Diagnostics by Product - Percentage Breakdown of Value Sales for Consumables and Instruments for the Years 2015, 2025 & 2030
    • TABLE 149: Asia-Pacific Recent Past, Current & Future Analysis for Hematology Diagnostics by Test Type - Blood count, Platelet function, Hemoglobin and Hematocrit - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 150: Asia-Pacific Historic Review for Hematology Diagnostics by Test Type - Blood count, Platelet function, Hemoglobin and Hematocrit Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 151: Asia-Pacific 15-Year Perspective for Hematology Diagnostics by Test Type - Percentage Breakdown of Value Sales for Blood count, Platelet function, Hemoglobin and Hematocrit for the Years 2015, 2025 & 2030
    • TABLE 152: Asia-Pacific Recent Past, Current & Future Analysis for Hematology Diagnostics by End-Use - Hospitals, Diagnostic Laboratories and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 153: Asia-Pacific Historic Review for Hematology Diagnostics by End-Use - Hospitals, Diagnostic Laboratories and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 154: Asia-Pacific 15-Year Perspective for Hematology Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals, Diagnostic Laboratories and Other End-Uses for the Years 2015, 2025 & 2030
  • AUSTRALIA
    • Hematology Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2025 (E)
    • TABLE 155: Australia Recent Past, Current & Future Analysis for Hematology Diagnostics by Product - Consumables and Instruments - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 156: Australia Historic Review for Hematology Diagnostics by Product - Consumables and Instruments Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 157: Australia 15-Year Perspective for Hematology Diagnostics by Product - Percentage Breakdown of Value Sales for Consumables and Instruments for the Years 2015, 2025 & 2030
    • TABLE 158: Australia Recent Past, Current & Future Analysis for Hematology Diagnostics by Test Type - Blood count, Platelet function, Hemoglobin and Hematocrit - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 159: Australia Historic Review for Hematology Diagnostics by Test Type - Blood count, Platelet function, Hemoglobin and Hematocrit Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 160: Australia 15-Year Perspective for Hematology Diagnostics by Test Type - Percentage Breakdown of Value Sales for Blood count, Platelet function, Hemoglobin and Hematocrit for the Years 2015, 2025 & 2030
    • TABLE 161: Australia Recent Past, Current & Future Analysis for Hematology Diagnostics by End-Use - Hospitals, Diagnostic Laboratories and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 162: Australia Historic Review for Hematology Diagnostics by End-Use - Hospitals, Diagnostic Laboratories and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 163: Australia 15-Year Perspective for Hematology Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals, Diagnostic Laboratories and Other End-Uses for the Years 2015, 2025 & 2030
  • INDIA
    • Hematology Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2025 (E)
    • TABLE 164: India Recent Past, Current & Future Analysis for Hematology Diagnostics by Product - Consumables and Instruments - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 165: India Historic Review for Hematology Diagnostics by Product - Consumables and Instruments Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 166: India 15-Year Perspective for Hematology Diagnostics by Product - Percentage Breakdown of Value Sales for Consumables and Instruments for the Years 2015, 2025 & 2030
    • TABLE 167: India Recent Past, Current & Future Analysis for Hematology Diagnostics by Test Type - Blood count, Platelet function, Hemoglobin and Hematocrit - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 168: India Historic Review for Hematology Diagnostics by Test Type - Blood count, Platelet function, Hemoglobin and Hematocrit Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 169: India 15-Year Perspective for Hematology Diagnostics by Test Type - Percentage Breakdown of Value Sales for Blood count, Platelet function, Hemoglobin and Hematocrit for the Years 2015, 2025 & 2030
    • TABLE 170: India Recent Past, Current & Future Analysis for Hematology Diagnostics by End-Use - Hospitals, Diagnostic Laboratories and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 171: India Historic Review for Hematology Diagnostics by End-Use - Hospitals, Diagnostic Laboratories and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 172: India 15-Year Perspective for Hematology Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals, Diagnostic Laboratories and Other End-Uses for the Years 2015, 2025 & 2030
  • SOUTH KOREA
    • TABLE 173: South Korea Recent Past, Current & Future Analysis for Hematology Diagnostics by Product - Consumables and Instruments - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 174: South Korea Historic Review for Hematology Diagnostics by Product - Consumables and Instruments Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 175: South Korea 15-Year Perspective for Hematology Diagnostics by Product - Percentage Breakdown of Value Sales for Consumables and Instruments for the Years 2015, 2025 & 2030
    • TABLE 176: South Korea Recent Past, Current & Future Analysis for Hematology Diagnostics by Test Type - Blood count, Platelet function, Hemoglobin and Hematocrit - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 177: South Korea Historic Review for Hematology Diagnostics by Test Type - Blood count, Platelet function, Hemoglobin and Hematocrit Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 178: South Korea 15-Year Perspective for Hematology Diagnostics by Test Type - Percentage Breakdown of Value Sales for Blood count, Platelet function, Hemoglobin and Hematocrit for the Years 2015, 2025 & 2030
    • TABLE 179: South Korea Recent Past, Current & Future Analysis for Hematology Diagnostics by End-Use - Hospitals, Diagnostic Laboratories and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 180: South Korea Historic Review for Hematology Diagnostics by End-Use - Hospitals, Diagnostic Laboratories and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 181: South Korea 15-Year Perspective for Hematology Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals, Diagnostic Laboratories and Other End-Uses for the Years 2015, 2025 & 2030
  • REST OF ASIA-PACIFIC
    • TABLE 182: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Hematology Diagnostics by Product - Consumables and Instruments - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 183: Rest of Asia-Pacific Historic Review for Hematology Diagnostics by Product - Consumables and Instruments Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 184: Rest of Asia-Pacific 15-Year Perspective for Hematology Diagnostics by Product - Percentage Breakdown of Value Sales for Consumables and Instruments for the Years 2015, 2025 & 2030
    • TABLE 185: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Hematology Diagnostics by Test Type - Blood count, Platelet function, Hemoglobin and Hematocrit - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 186: Rest of Asia-Pacific Historic Review for Hematology Diagnostics by Test Type - Blood count, Platelet function, Hemoglobin and Hematocrit Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 187: Rest of Asia-Pacific 15-Year Perspective for Hematology Diagnostics by Test Type - Percentage Breakdown of Value Sales for Blood count, Platelet function, Hemoglobin and Hematocrit for the Years 2015, 2025 & 2030
    • TABLE 188: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Hematology Diagnostics by End-Use - Hospitals, Diagnostic Laboratories and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 189: Rest of Asia-Pacific Historic Review for Hematology Diagnostics by End-Use - Hospitals, Diagnostic Laboratories and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 190: Rest of Asia-Pacific 15-Year Perspective for Hematology Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals, Diagnostic Laboratories and Other End-Uses for the Years 2015, 2025 & 2030
  • LATIN AMERICA
    • Hematology Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2025 (E)
    • TABLE 191: Latin America Recent Past, Current & Future Analysis for Hematology Diagnostics by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 192: Latin America Historic Review for Hematology Diagnostics by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 193: Latin America 15-Year Perspective for Hematology Diagnostics by Geographic Region - Percentage Breakdown of Value Sales for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2015, 2025 & 2030
    • TABLE 194: Latin America Recent Past, Current & Future Analysis for Hematology Diagnostics by Product - Consumables and Instruments - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 195: Latin America Historic Review for Hematology Diagnostics by Product - Consumables and Instruments Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 196: Latin America 15-Year Perspective for Hematology Diagnostics by Product - Percentage Breakdown of Value Sales for Consumables and Instruments for the Years 2015, 2025 & 2030
    • TABLE 197: Latin America Recent Past, Current & Future Analysis for Hematology Diagnostics by Test Type - Blood count, Platelet function, Hemoglobin and Hematocrit - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 198: Latin America Historic Review for Hematology Diagnostics by Test Type - Blood count, Platelet function, Hemoglobin and Hematocrit Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 199: Latin America 15-Year Perspective for Hematology Diagnostics by Test Type - Percentage Breakdown of Value Sales for Blood count, Platelet function, Hemoglobin and Hematocrit for the Years 2015, 2025 & 2030
    • TABLE 200: Latin America Recent Past, Current & Future Analysis for Hematology Diagnostics by End-Use - Hospitals, Diagnostic Laboratories and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 201: Latin America Historic Review for Hematology Diagnostics by End-Use - Hospitals, Diagnostic Laboratories and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 202: Latin America 15-Year Perspective for Hematology Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals, Diagnostic Laboratories and Other End-Uses for the Years 2015, 2025 & 2030
  • ARGENTINA
    • TABLE 203: Argentina Recent Past, Current & Future Analysis for Hematology Diagnostics by Product - Consumables and Instruments - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 204: Argentina Historic Review for Hematology Diagnostics by Product - Consumables and Instruments Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 205: Argentina 15-Year Perspective for Hematology Diagnostics by Product - Percentage Breakdown of Value Sales for Consumables and Instruments for the Years 2015, 2025 & 2030
    • TABLE 206: Argentina Recent Past, Current & Future Analysis for Hematology Diagnostics by Test Type - Blood count, Platelet function, Hemoglobin and Hematocrit - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 207: Argentina Historic Review for Hematology Diagnostics by Test Type - Blood count, Platelet function, Hemoglobin and Hematocrit Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 208: Argentina 15-Year Perspective for Hematology Diagnostics by Test Type - Percentage Breakdown of Value Sales for Blood count, Platelet function, Hemoglobin and Hematocrit for the Years 2015, 2025 & 2030
    • TABLE 209: Argentina Recent Past, Current & Future Analysis for Hematology Diagnostics by End-Use - Hospitals, Diagnostic Laboratories and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 210: Argentina Historic Review for Hematology Diagnostics by End-Use - Hospitals, Diagnostic Laboratories and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 211: Argentina 15-Year Perspective for Hematology Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals, Diagnostic Laboratories and Other End-Uses for the Years 2015, 2025 & 2030
  • BRAZIL
    • TABLE 212: Brazil Recent Past, Current & Future Analysis for Hematology Diagnostics by Product - Consumables and Instruments - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 213: Brazil Historic Review for Hematology Diagnostics by Product - Consumables and Instruments Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 214: Brazil 15-Year Perspective for Hematology Diagnostics by Product - Percentage Breakdown of Value Sales for Consumables and Instruments for the Years 2015, 2025 & 2030
    • TABLE 215: Brazil Recent Past, Current & Future Analysis for Hematology Diagnostics by Test Type - Blood count, Platelet function, Hemoglobin and Hematocrit - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 216: Brazil Historic Review for Hematology Diagnostics by Test Type - Blood count, Platelet function, Hemoglobin and Hematocrit Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 217: Brazil 15-Year Perspective for Hematology Diagnostics by Test Type - Percentage Breakdown of Value Sales for Blood count, Platelet function, Hemoglobin and Hematocrit for the Years 2015, 2025 & 2030
    • TABLE 218: Brazil Recent Past, Current & Future Analysis for Hematology Diagnostics by End-Use - Hospitals, Diagnostic Laboratories and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 219: Brazil Historic Review for Hematology Diagnostics by End-Use - Hospitals, Diagnostic Laboratories and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 220: Brazil 15-Year Perspective for Hematology Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals, Diagnostic Laboratories and Other End-Uses for the Years 2015, 2025 & 2030
  • MEXICO
    • TABLE 221: Mexico Recent Past, Current & Future Analysis for Hematology Diagnostics by Product - Consumables and Instruments - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 222: Mexico Historic Review for Hematology Diagnostics by Product - Consumables and Instruments Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 223: Mexico 15-Year Perspective for Hematology Diagnostics by Product - Percentage Breakdown of Value Sales for Consumables and Instruments for the Years 2015, 2025 & 2030
    • TABLE 224: Mexico Recent Past, Current & Future Analysis for Hematology Diagnostics by Test Type - Blood count, Platelet function, Hemoglobin and Hematocrit - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 225: Mexico Historic Review for Hematology Diagnostics by Test Type - Blood count, Platelet function, Hemoglobin and Hematocrit Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 226: Mexico 15-Year Perspective for Hematology Diagnostics by Test Type - Percentage Breakdown of Value Sales for Blood count, Platelet function, Hemoglobin and Hematocrit for the Years 2015, 2025 & 2030
    • TABLE 227: Mexico Recent Past, Current & Future Analysis for Hematology Diagnostics by End-Use - Hospitals, Diagnostic Laboratories and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 228: Mexico Historic Review for Hematology Diagnostics by End-Use - Hospitals, Diagnostic Laboratories and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 229: Mexico 15-Year Perspective for Hematology Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals, Diagnostic Laboratories and Other End-Uses for the Years 2015, 2025 & 2030
  • REST OF LATIN AMERICA
    • TABLE 230: Rest of Latin America Recent Past, Current & Future Analysis for Hematology Diagnostics by Product - Consumables and Instruments - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 231: Rest of Latin America Historic Review for Hematology Diagnostics by Product - Consumables and Instruments Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 232: Rest of Latin America 15-Year Perspective for Hematology Diagnostics by Product - Percentage Breakdown of Value Sales for Consumables and Instruments for the Years 2015, 2025 & 2030
    • TABLE 233: Rest of Latin America Recent Past, Current & Future Analysis for Hematology Diagnostics by Test Type - Blood count, Platelet function, Hemoglobin and Hematocrit - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 234: Rest of Latin America Historic Review for Hematology Diagnostics by Test Type - Blood count, Platelet function, Hemoglobin and Hematocrit Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 235: Rest of Latin America 15-Year Perspective for Hematology Diagnostics by Test Type - Percentage Breakdown of Value Sales for Blood count, Platelet function, Hemoglobin and Hematocrit for the Years 2015, 2025 & 2030
    • TABLE 236: Rest of Latin America Recent Past, Current & Future Analysis for Hematology Diagnostics by End-Use - Hospitals, Diagnostic Laboratories and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 237: Rest of Latin America Historic Review for Hematology Diagnostics by End-Use - Hospitals, Diagnostic Laboratories and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 238: Rest of Latin America 15-Year Perspective for Hematology Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals, Diagnostic Laboratories and Other End-Uses for the Years 2015, 2025 & 2030
  • MIDDLE EAST
    • Hematology Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2025 (E)
    • TABLE 239: Middle East Recent Past, Current & Future Analysis for Hematology Diagnostics by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 240: Middle East Historic Review for Hematology Diagnostics by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 241: Middle East 15-Year Perspective for Hematology Diagnostics by Geographic Region - Percentage Breakdown of Value Sales for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2015, 2025 & 2030
    • TABLE 242: Middle East Recent Past, Current & Future Analysis for Hematology Diagnostics by Product - Consumables and Instruments - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 243: Middle East Historic Review for Hematology Diagnostics by Product - Consumables and Instruments Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 244: Middle East 15-Year Perspective for Hematology Diagnostics by Product - Percentage Breakdown of Value Sales for Consumables and Instruments for the Years 2015, 2025 & 2030
    • TABLE 245: Middle East Recent Past, Current & Future Analysis for Hematology Diagnostics by Test Type - Blood count, Platelet function, Hemoglobin and Hematocrit - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 246: Middle East Historic Review for Hematology Diagnostics by Test Type - Blood count, Platelet function, Hemoglobin and Hematocrit Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 247: Middle East 15-Year Perspective for Hematology Diagnostics by Test Type - Percentage Breakdown of Value Sales for Blood count, Platelet function, Hemoglobin and Hematocrit for the Years 2015, 2025 & 2030
    • TABLE 248: Middle East Recent Past, Current & Future Analysis for Hematology Diagnostics by End-Use - Hospitals, Diagnostic Laboratories and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 249: Middle East Historic Review for Hematology Diagnostics by End-Use - Hospitals, Diagnostic Laboratories and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 250: Middle East 15-Year Perspective for Hematology Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals, Diagnostic Laboratories and Other End-Uses for the Years 2015, 2025 & 2030
  • IRAN
    • TABLE 251: Iran Recent Past, Current & Future Analysis for Hematology Diagnostics by Product - Consumables and Instruments - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 252: Iran Historic Review for Hematology Diagnostics by Product - Consumables and Instruments Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 253: Iran 15-Year Perspective for Hematology Diagnostics by Product - Percentage Breakdown of Value Sales for Consumables and Instruments for the Years 2015, 2025 & 2030
    • TABLE 254: Iran Recent Past, Current & Future Analysis for Hematology Diagnostics by Test Type - Blood count, Platelet function, Hemoglobin and Hematocrit - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 255: Iran Historic Review for Hematology Diagnostics by Test Type - Blood count, Platelet function, Hemoglobin and Hematocrit Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 256: Iran 15-Year Perspective for Hematology Diagnostics by Test Type - Percentage Breakdown of Value Sales for Blood count, Platelet function, Hemoglobin and Hematocrit for the Years 2015, 2025 & 2030
    • TABLE 257: Iran Recent Past, Current & Future Analysis for Hematology Diagnostics by End-Use - Hospitals, Diagnostic Laboratories and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 258: Iran Historic Review for Hematology Diagnostics by End-Use - Hospitals, Diagnostic Laboratories and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 259: Iran 15-Year Perspective for Hematology Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals, Diagnostic Laboratories and Other End-Uses for the Years 2015, 2025 & 2030
  • ISRAEL
    • TABLE 260: Israel Recent Past, Current & Future Analysis for Hematology Diagnostics by Product - Consumables and Instruments - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 261: Israel Historic Review for Hematology Diagnostics by Product - Consumables and Instruments Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 262: Israel 15-Year Perspective for Hematology Diagnostics by Product - Percentage Breakdown of Value Sales for Consumables and Instruments for the Years 2015, 2025 & 2030
    • TABLE 263: Israel Recent Past, Current & Future Analysis for Hematology Diagnostics by Test Type - Blood count, Platelet function, Hemoglobin and Hematocrit - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 264: Israel Historic Review for Hematology Diagnostics by Test Type - Blood count, Platelet function, Hemoglobin and Hematocrit Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 265: Israel 15-Year Perspective for Hematology Diagnostics by Test Type - Percentage Breakdown of Value Sales for Blood count, Platelet function, Hemoglobin and Hematocrit for the Years 2015, 2025 & 2030
    • TABLE 266: Israel Recent Past, Current & Future Analysis for Hematology Diagnostics by End-Use - Hospitals, Diagnostic Laboratories and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 267: Israel Historic Review for Hematology Diagnostics by End-Use - Hospitals, Diagnostic Laboratories and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 268: Israel 15-Year Perspective for Hematology Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals, Diagnostic Laboratories and Other End-Uses for the Years 2015, 2025 & 2030
  • SAUDI ARABIA
    • TABLE 269: Saudi Arabia Recent Past, Current & Future Analysis for Hematology Diagnostics by Product - Consumables and Instruments - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 270: Saudi Arabia Historic Review for Hematology Diagnostics by Product - Consumables and Instruments Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 271: Saudi Arabia 15-Year Perspective for Hematology Diagnostics by Product - Percentage Breakdown of Value Sales for Consumables and Instruments for the Years 2015, 2025 & 2030
    • TABLE 272: Saudi Arabia Recent Past, Current & Future Analysis for Hematology Diagnostics by Test Type - Blood count, Platelet function, Hemoglobin and Hematocrit - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 273: Saudi Arabia Historic Review for Hematology Diagnostics by Test Type - Blood count, Platelet function, Hemoglobin and Hematocrit Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 274: Saudi Arabia 15-Year Perspective for Hematology Diagnostics by Test Type - Percentage Breakdown of Value Sales for Blood count, Platelet function, Hemoglobin and Hematocrit for the Years 2015, 2025 & 2030
    • TABLE 275: Saudi Arabia Recent Past, Current & Future Analysis for Hematology Diagnostics by End-Use - Hospitals, Diagnostic Laboratories and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 276: Saudi Arabia Historic Review for Hematology Diagnostics by End-Use - Hospitals, Diagnostic Laboratories and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 277: Saudi Arabia 15-Year Perspective for Hematology Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals, Diagnostic Laboratories and Other End-Uses for the Years 2015, 2025 & 2030
  • UNITED ARAB EMIRATES
    • TABLE 278: UAE Recent Past, Current & Future Analysis for Hematology Diagnostics by Product - Consumables and Instruments - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 279: UAE Historic Review for Hematology Diagnostics by Product - Consumables and Instruments Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 280: UAE 15-Year Perspective for Hematology Diagnostics by Product - Percentage Breakdown of Value Sales for Consumables and Instruments for the Years 2015, 2025 & 2030
    • TABLE 281: UAE Recent Past, Current & Future Analysis for Hematology Diagnostics by Test Type - Blood count, Platelet function, Hemoglobin and Hematocrit - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 282: UAE Historic Review for Hematology Diagnostics by Test Type - Blood count, Platelet function, Hemoglobin and Hematocrit Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 283: UAE 15-Year Perspective for Hematology Diagnostics by Test Type - Percentage Breakdown of Value Sales for Blood count, Platelet function, Hemoglobin and Hematocrit for the Years 2015, 2025 & 2030
    • TABLE 284: UAE Recent Past, Current & Future Analysis for Hematology Diagnostics by End-Use - Hospitals, Diagnostic Laboratories and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 285: UAE Historic Review for Hematology Diagnostics by End-Use - Hospitals, Diagnostic Laboratories and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 286: UAE 15-Year Perspective for Hematology Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals, Diagnostic Laboratories and Other End-Uses for the Years 2015, 2025 & 2030
  • REST OF MIDDLE EAST
    • TABLE 287: Rest of Middle East Recent Past, Current & Future Analysis for Hematology Diagnostics by Product - Consumables and Instruments - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 288: Rest of Middle East Historic Review for Hematology Diagnostics by Product - Consumables and Instruments Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 289: Rest of Middle East 15-Year Perspective for Hematology Diagnostics by Product - Percentage Breakdown of Value Sales for Consumables and Instruments for the Years 2015, 2025 & 2030
    • TABLE 290: Rest of Middle East Recent Past, Current & Future Analysis for Hematology Diagnostics by Test Type - Blood count, Platelet function, Hemoglobin and Hematocrit - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 291: Rest of Middle East Historic Review for Hematology Diagnostics by Test Type - Blood count, Platelet function, Hemoglobin and Hematocrit Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 292: Rest of Middle East 15-Year Perspective for Hematology Diagnostics by Test Type - Percentage Breakdown of Value Sales for Blood count, Platelet function, Hemoglobin and Hematocrit for the Years 2015, 2025 & 2030
    • TABLE 293: Rest of Middle East Recent Past, Current & Future Analysis for Hematology Diagnostics by End-Use - Hospitals, Diagnostic Laboratories and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 294: Rest of Middle East Historic Review for Hematology Diagnostics by End-Use - Hospitals, Diagnostic Laboratories and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 295: Rest of Middle East 15-Year Perspective for Hematology Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals, Diagnostic Laboratories and Other End-Uses for the Years 2015, 2025 & 2030
  • AFRICA
    • Hematology Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2025 (E)
    • TABLE 296: Africa Recent Past, Current & Future Analysis for Hematology Diagnostics by Product - Consumables and Instruments - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 297: Africa Historic Review for Hematology Diagnostics by Product - Consumables and Instruments Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 298: Africa 15-Year Perspective for Hematology Diagnostics by Product - Percentage Breakdown of Value Sales for Consumables and Instruments for the Years 2015, 2025 & 2030
    • TABLE 299: Africa Recent Past, Current & Future Analysis for Hematology Diagnostics by Test Type - Blood count, Platelet function, Hemoglobin and Hematocrit - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 300: Africa Historic Review for Hematology Diagnostics by Test Type - Blood count, Platelet function, Hemoglobin and Hematocrit Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 301: Africa 15-Year Perspective for Hematology Diagnostics by Test Type - Percentage Breakdown of Value Sales for Blood count, Platelet function, Hemoglobin and Hematocrit for the Years 2015, 2025 & 2030
    • TABLE 302: Africa Recent Past, Current & Future Analysis for Hematology Diagnostics by End-Use - Hospitals, Diagnostic Laboratories and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 303: Africa Historic Review for Hematology Diagnostics by End-Use - Hospitals, Diagnostic Laboratories and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 304: Africa 15-Year Perspective for Hematology Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals, Diagnostic Laboratories and Other End-Uses for the Years 2015, 2025 & 2030

IV. COMPETITION